BHARAT BIOTECH INTERNATIONAL LIMITED

Bharat Biotech International Limited Company Introduction

Bharat Biotech International Limited is a Manufacturer.

Company Introduction:

Bharat Biotech International Limited is a leading Indian multinational biotechnology company headquartered in Hyderabad, India. Founded in 1996 by Dr. Krishna Ella, the company is globally recognized for its pioneering work in the research, development, and manufacturing of vaccines, biotherapeutics, pharmaceuticals, and healthcare products.

Bharat Biotech operates state-of-the-art manufacturing facilities, making it a key player in the global vaccine market. It has developed and commercialized a wide range of vaccines for infectious diseases, including polio, rotavirus, Japanese encephalitis, chikungunya, and most notably, Covaxin, India's indigenous COVID-19 vaccine. The company is committed to innovation and public health, contributing significantly to disease prevention and global health security through its advanced biotechnological capabilities and extensive production capacity.

Bharat Biotech International Limited manufactures or sells the following products:

1 Covaxin (COVID-19 Vaccine)

2 Rotavac (Rotavirus Vaccine)

3 Typbar TCV (Typhoid Conjugate Vaccine)

4 Comvac5 (Pentavalent Vaccine - DPT-HepB-Hib)

5 Recombivax HB (Hepatitis B Vaccine)

6 Indirab (Rabies Vaccine)

7 Biopolio (Oral Polio Vaccine)

8 JENVAC (Japanese Encephalitis Vaccine)

9 TetTox (Tetanus Toxoid)

10 DIPHTEC (Diphtheria Tetanus Vaccine)

11 Vaxiprab (Rabies Monoclonal Antibody)